Get the Stockscreener App
58.36
0.60%
-0.35
Proshares Ultra Health Care 2 X Shares Stock (RXL) Forecast
The Proshares Ultra Health Care 2 X Shares (RXL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $166.00, representing a +184.45% increase from the current price of $58.36. The highest analyst price target is $171.95, and the lowest is $160.05.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RXL Price Target
Average 169.85
(+191.03% Upside)
Is Proshares Ultra Health Care 2 X Shares (RXL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 39.93 | Neutral |
| STOCH(9,6) | 11.95 | Buy |
| STOCHRSI(14) | 27.35 | Neutral |
| MACD(12,26) | 0.0485 | Sell |
| ADX(14) | 23.74 | Neutral |
| William %R | -99.33 | Buy |
| CCI(14) | -123.37 | Sell |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
59.42
Sell
|
58.83
Sell
|
| MA20 |
60.47
Sell
|
59.25
Sell
|
| MA50 |
57.53
Sell
|
57.29
Sell
|
| MA100 |
52.28
Buy
|
54.45
Buy
|
| MA200 |
51.48
Buy
|
51.02
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, RXL could be considered a Moderate Sell, with 17 technical analysis indicators signaling 6 Buy signals, 8 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on RXL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 39.93 indicates that RXL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 11.95 indicates that RXL is oversold. This indicates that RXL price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 27.35 indicates that RXL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.74 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -123.37 indicates that RXL is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term RXL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Proshares Ultra Health Care 2 X Shares financial reports and earnings history, Proshares Ultra Health Care 2 X Shares (RXL) stock could reach $146.51 by 2030, $340.37 by 2040 and $463.78 by 2050. See the projected annual prices until 2050 of the Proshares Ultra Health Care 2 X Shares stock below:
- Proshares Ultra Health Care 2 X Shares (RXL) is expected to reach an average price of $260.05 in 2035, with a high prediction of $260.05 and a low estimate of $249.65. This indicates an $345.60% rise from the last recorded price of $58.36.
- Proshares Ultra Health Care 2 X Shares (RXL) stock is projected to chart a bullish course in 2040, with an average price target of $337.84, representing an $478.90% surge from its current level. The forecast ranges from a conservative $332.75 to a sky-high $340.37.
- Our analysts predict Proshares Ultra Health Care 2 X Shares (RXL) to jump 565.38% by 2045, soaring from $385.66 to an average price of $388.31, potentially reaching $399.81. While $385.66 is the low estimate, the potential upside is significant.
- Proshares Ultra Health Care 2 X Shares (RXL) stock is expected to climb by 2050, reaching an average of $463.63, a $694.43% jump from its current level. However, a wide range of estimates exists, with high and low targets of $463.78 and $449.82, respectively, highlighting the market's uncertainty.
Proshares Ultra Health Care 2 X Shares Stock (RXL) Year by Year Forecast
Proshares Ultra Health Care 2 X Shares Stock (RXL) Price Forecast for 2026
The predicted value for Proshares Ultra Health Care 2 X Shares (RXL) in 2026 is set at an average of $149.33. Estimates vary from a peak of $176.91 to a trough of $121.74, indicating an +155.87% surge from the present price of $58.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| October, 2026 | $169.73 | $160.05 | $171.95 | +190.84% |
| November, 2026 | $173.81 | $167.79 | $175.71 | +197.82% |
| December, 2026 | $163.71 | $163.32 | $176.91 | +180.51% |
Proshares Ultra Health Care 2 X Shares Stock (RXL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Proshares Ultra Health Care 2 X Shares (RXL) is $166.70, with a high forecast of $184.50 and a low forecast of $148.91. This indicates an +185.64% increase from the last price of $58.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $169.40 | $159.16 | $169.40 | +190.27% |
| February, 2027 | $170.87 | $168.69 | $175.26 | +192.79% |
| March, 2027 | $177.40 | $164.52 | $179.33 | +203.98% |
| April, 2027 | $170.16 | $168.46 | $184.04 | +191.57% |
| May, 2027 | $167.54 | $156.69 | $169.36 | +187.07% |
| June, 2027 | $167.75 | $155.20 | $171.32 | +187.44% |
| July, 2027 | $175.00 | $161.08 | $177.65 | +199.86% |
| August, 2027 | $169.58 | $169.57 | $184.50 | +190.58% |
| September, 2027 | $169.13 | $156.51 | $171.20 | +189.81% |
| October, 2027 | $150.86 | $148.91 | $168.05 | +158.49% |
| November, 2027 | $167.19 | $152.32 | $168.12 | +186.48% |
| December, 2027 | $171.42 | $159.41 | $171.78 | +193.73% |
Proshares Ultra Health Care 2 X Shares Stock (RXL) Price Forecast for 2028
In 2028, Proshares Ultra Health Care 2 X Shares (RXL) is projected to reach an average price of $167.07, with a high projection of $181.57 and a low estimate of $152.57. This indicates an +186.27% rise from the last price of $58.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $158.96 | $158.37 | $172.57 | +172.38% |
| February, 2028 | $154.42 | $154.14 | $168.95 | +164.60% |
| March, 2028 | $169.13 | $152.57 | $169.60 | +189.80% |
| April, 2028 | $174.82 | $164.13 | $174.91 | +199.56% |
| May, 2028 | $174.28 | $171.86 | $181.57 | +198.63% |
| June, 2028 | $172.35 | $170.56 | $175.61 | +195.32% |
| July, 2028 | $170.56 | $169.14 | $173.63 | +192.26% |
| August, 2028 | $159.83 | $159.35 | $172.63 | +173.87% |
| September, 2028 | $172.87 | $158.69 | $173.24 | +196.20% |
| October, 2028 | $173.07 | $169.82 | $176.01 | +196.55% |
| November, 2028 | $168.84 | $163.62 | $172.80 | +189.31% |
| December, 2028 | $173.07 | $166.00 | $173.29 | +196.56% |
Proshares Ultra Health Care 2 X Shares Stock (RXL) Price Forecast for 2029
The 2029 price forecast for Proshares Ultra Health Care 2 X Shares Stock (RXL) is $169.07 on average, with a high prediction of $197.48 and a low estimate of $140.66. This represents an +189.70% increase from the previous price of $58.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $174.80 | $167.82 | $178.46 | +199.52% |
| February, 2029 | $174.14 | $172.53 | $177.87 | +198.38% |
| March, 2029 | $172.74 | $171.24 | $176.57 | +195.99% |
| April, 2029 | $170.78 | $166.96 | $173.82 | +192.63% |
| May, 2029 | $166.14 | $161.39 | $172.31 | +184.68% |
| June, 2029 | $173.43 | $165.81 | $173.43 | +197.17% |
| July, 2029 | $180.04 | $172.87 | $180.32 | +208.50% |
| August, 2029 | $186.02 | $180.02 | $187.74 | +218.75% |
| September, 2029 | $196.55 | $185.46 | $196.55 | +236.79% |
| October, 2029 | $193.85 | $192.26 | $195.90 | +232.16% |
| November, 2029 | $184.62 | $182.59 | $197.48 | +216.35% |
| December, 2029 | $142.14 | $140.66 | $188.15 | +143.56% |
Proshares Ultra Health Care 2 X Shares Stock (RXL) Price Forecast for 2030
Proshares Ultra Health Care 2 X Shares Stock (RXL) is expected to reach an average price of $157.12 in 2030, with a high forecast of $174.14 and a low forecast of $140.09. This signifies an +169.22% surge from the last price of $58.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $145.78 | $140.09 | $146.51 | +149.79% |
| February, 2030 | $148.53 | $146.02 | $150.62 | +154.51% |
| March, 2030 | $148.28 | $147.90 | $149.94 | +154.07% |
| April, 2030 | $148.70 | $145.88 | $150.06 | +154.79% |
| May, 2030 | $149.74 | $147.33 | $151.79 | +156.58% |
| June, 2030 | $152.80 | $147.01 | $153.51 | +161.82% |
| July, 2030 | $161.52 | $154.01 | $161.55 | +176.76% |
| August, 2030 | $168.45 | $162.23 | $168.67 | +188.63% |
| September, 2030 | $170.56 | $167.32 | $171.06 | +192.26% |
| October, 2030 | $173.11 | $166.40 | $174.14 | +196.63% |
| November, 2030 | $152.80 | $149.74 | $174.12 | +161.82% |
| December, 2030 | $152.27 | $140.74 | $154.94 | +160.92% |
0.36%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):